A warm welcome!
In Norway, Sweden and Denmark, we’ve been in close dialogue with startups and the health clusters, and we’re actively working on promoting the industry and the companies through our conferences in Oslo, Stockholm and New York. This is something our large, international customers value, as they get unique insights into interesting Nordic companies and technologies, which increase the chances of partnerships and collaborations forming, or acquisitions taking place.
DNB Nordic Healthcare Conference 2021
This year, the 12th DNB Nordic Healthcare Conference was held on 16 December 2021. This conference has become one of DNB’s most important events in the sector.
This year the conference consisted of The Listed Session and DNB NXT Healthcare Venture Session.
About the conference
Whether you’re a company that’s eager to get in touch with a broad spectrum of investors, polish your pitch or create new partnerships, this is an annual event you don’t want to miss. For investors on the hunt for new opportunities, the conference represents a unique arena for networking and finding the next investment candidate.
Duration 0:27 minutes
Nordic Life Science Days
Nordic Life Science Days is the largest Nordic partner conference in the life science industry.
DNB has been an active partner since 2016 and is responsible for the session ‘Follow the Money - Investors Leading the Way to Sustainability’. The next conference is taking place in:
Malmö, 19-21 April 2022
The Nordic-American Life Science Conference
The Nordic-American Life Science Conference is held at the Wellsaid Convene Venue (42nd) in:
New York, 2 December 2022
Biopharma, Medtech, Health Tech and Life Science companies will be in attendance. Hear presentations from innovative, private/pre-IPO companies, and get insights into investment opportunities. One-to-one discussions will be facilitated, with the chance to have informal chats during and after the conference.
The conference is held in person and can be viewed digitally afterwards. Participants consist of global investors, American and European companies in healthcare and various Nordic technology partners.